Riganti C - Search Results

1

FLVCR1a Controls Cellular Cholesterol Levels through the Regulation of Heme Biosynthesis and Tricarboxylic Acid Cycle Flux in Endothelial Cells.

Manco M, Ammirata G, Petrillo S, De Giorgio F, Fontana S, Riganti C, Provero P, Fagoonee S, Altruda F, Tolosano E. Manco M, et al. Among authors: riganti c. Biomolecules. 2024 Jan 26;14(2):149. doi: 10.3390/biom14020149. Biomolecules. 2024. PMID: 38397386 Free PMC article.

2

The heme synthesis-export system regulates the tricarboxylic acid cycle flux and oxidative phosphorylation.

Fiorito V, Allocco AL, Petrillo S, Gazzano E, Torretta S, Marchi S, Destefanis F, Pacelli C, Audrito V, Provero P, Medico E, Chiabrando D, Porporato PE, Cancelliere C, Bardelli A, Trusolino L, Capitanio N, Deaglio S, Altruda F, Pinton P, Cardaci S, Riganti C, Tolosano E. Fiorito V, et al. Among authors: riganti c. Cell Rep. 2021 Jun 15;35(11):109252. doi: 10.1016/j.celrep.2021.109252. Cell Rep. 2021. PMID: 34133926 Free article.

3

Endothelial Heme Dynamics Drive Cancer Cell Metabolism by Shaping the Tumor Microenvironment.

Petrillo S, De Giorgio F, Kopecka J, Genova T, Fiorito V, Allocco AL, Bertino F, Chiabrando D, Mussano F, Altruda F, Munaron L, Riganti C, Tolosano E. Petrillo S, et al. Among authors: riganti c. Biomedicines. 2021 Oct 28;9(11):1557. doi: 10.3390/biomedicines9111557. Biomedicines. 2021. PMID: 34829786 Free PMC article.

4

Inhibition of Heme Export and/or Heme Synthesis Potentiates Metformin Anti-Proliferative Effect on Cancer Cell Lines.

Allocco AL, Bertino F, Petrillo S, Chiabrando D, Riganti C, Bardelli A, Altruda F, Fiorito V, Tolosano E. Allocco AL, et al. Among authors: riganti c. Cancers (Basel). 2022 Feb 27;14(5):1230. doi: 10.3390/cancers14051230. Cancers (Basel). 2022. PMID: 35267538 Free PMC article.

5

Endothelial Cells Promote Osteogenesis by Establishing a Functional and Metabolic Coupling With Human Mesenchymal Stem Cells.

Petrillo S, Genova T, Chinigò G, Roato I, Scarpellino G, Kopecka J, Altruda F, Tolosano E, Riganti C, Mussano F, Munaron L. Petrillo S, et al. Among authors: riganti c. Front Physiol. 2022 Jan 11;12:813547. doi: 10.3389/fphys.2021.813547. eCollection 2021. Front Physiol. 2022. PMID: 35087424 Free PMC article.

6

Impedance-based drug-resistance characterization of colon cancer cells through real-time cell culture monitoring.

Fuentes-Vélez S, Fagoonee S, Sanginario A, Gallo V, Riganti C, Pizzi M, Altruda F, Demarchi D. Fuentes-Vélez S, et al. Among authors: riganti c. Talanta. 2021 Jan 15;222:121441. doi: 10.1016/j.talanta.2020.121441. Epub 2020 Aug 25. Talanta. 2021. PMID: 33167197

7

Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.

Tassone B, Saoncella S, Neri F, Ala U, Brusa D, Magnuson MA, Provero P, Oliviero S, Riganti C, Calautti E. Tassone B, et al. Among authors: riganti c. Cell Death Differ. 2017 Apr;24(4):731-746. doi: 10.1038/cdd.2017.8. Epub 2017 Feb 17. Cell Death Differ. 2017. PMID: 28211872 Free PMC article.

8

PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy.

Salaroglio IC, Panada E, Moiso E, Buondonno I, Provero P, Rubinstein M, Kopecka J, Riganti C. Salaroglio IC, et al. Among authors: riganti c. Mol Cancer. 2017 May 12;16(1):91. doi: 10.1186/s12943-017-0657-0. Mol Cancer. 2017. PMID: 28499449 Free PMC article.

9

Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.

Salaroglio IC, Belisario DC, Akman M, La Vecchia S, Godel M, Anobile DP, Ortone G, Digiovanni S, Fontana S, Costamagna C, Rubinstein M, Kopecka J, Riganti C. Salaroglio IC, et al. Among authors: riganti c. J Exp Clin Cancer Res. 2022 Aug 11;41(1):243. doi: 10.1186/s13046-022-02447-6. J Exp Clin Cancer Res. 2022. PMID: 35953814 Free PMC article.

10

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.

Salaroglio IC, Belisario DC, Bironzo P, Ananthanarayanan P, Ricci L, Digiovanni S, Fontana S, Napoli F, Sandri A, Facolmatà C, Libener R, Comunanza V, Grosso F, Gazzano E, Leo F, Taulli R, Bussolino F, Righi L, Papotti MG, Novello S, Scagliotti GV, Riganti C, Kopecka J. Salaroglio IC, et al. Among authors: riganti c. J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7. J Exp Clin Cancer Res. 2022. PMID: 35197103 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page